X Liao1, B Li2, Z Cheng3. 1. Department of Anesthesiology, Zhongshan Hospital Affiliated to Sun Yat-sen University, East Sunwen Road, Zhongshan City, 528403, Zhongshan, Guangdong Province, China. liaoxiaozu@163.com. 2. Department of Anesthesiology, Zhongshan Hospital Affiliated to Sun Yat-sen University, East Sunwen Road, Zhongshan City, 528403, Zhongshan, Guangdong Province, China. 286025919@qq.com. 3. Department of Anesthesiology, Zhongshan Hospital Affiliated to Sun Yat-sen University, East Sunwen Road, Zhongshan City, 528403, Zhongshan, Guangdong Province, China.
Abstract
BACKGROUND: Our study aimed to summarize the clinical outcomes of extracorporeal membrane oxygenation (ECMO) in adult patients with acute fulminant myocarditis and to investigate the risk factors associated with its application. PATIENTS AND METHODS: We retrospectively examined patients with cardiogenic shock and acute fulminant myocarditis. The following data were collected: patients' preoperative general condition, related clinical factors during ECMO, complications, and outcomes of ECMO. The patients were divided into a survivor group and a nonsurvivor group. RESULTS: From a total of 33 patients, seven died in hospital. The survival rate was 78.7%. The following complications were observed during ECMO: 16 cases of acute renal failure (48.4%), seven cases of sepsis (21.2%), six cases of pulmonary infection (18.1%), six cases of multiple organ failure (MOF; 18.1%), three cases of cerebral hemorrhage (9%), and four cases of limb ischemia (12.1%). Pre-ECMO cardiopulmonary resuscitation, high levels of lactic acid, high amounts of blood transfusion during ECMO, renal failure, encephalorrhagia, gastrointestinal complications, lower-limb ischemia, high bilirubin levels, and MOF during ECMO were associated with unfavorable patient outcomes. CONCLUSION: ECMO is an effective auxiliary tool for treating acute fulminant myocarditis. Acute renal failure is the most common complication during ECMO. Improving tissue perfusion, reducing blood transfusions, and preventing acute kidney failure may improve patient outcomes.
BACKGROUND: Our study aimed to summarize the clinical outcomes of extracorporeal membrane oxygenation (ECMO) in adult patients with acute fulminant myocarditis and to investigate the risk factors associated with its application. PATIENTS AND METHODS: We retrospectively examined patients with cardiogenic shock and acute fulminant myocarditis. The following data were collected: patients' preoperative general condition, related clinical factors during ECMO, complications, and outcomes of ECMO. The patients were divided into a survivor group and a nonsurvivor group. RESULTS: From a total of 33 patients, seven died in hospital. The survival rate was 78.7%. The following complications were observed during ECMO: 16 cases of acute renal failure (48.4%), seven cases of sepsis (21.2%), six cases of pulmonary infection (18.1%), six cases of multiple organ failure (MOF; 18.1%), three cases of cerebral hemorrhage (9%), and four cases of limb ischemia (12.1%). Pre-ECMO cardiopulmonary resuscitation, high levels of lactic acid, high amounts of blood transfusion during ECMO, renal failure, encephalorrhagia, gastrointestinal complications, lower-limb ischemia, high bilirubin levels, and MOF during ECMO were associated with unfavorable patient outcomes. CONCLUSION: ECMO is an effective auxiliary tool for treating acute fulminant myocarditis. Acute renal failure is the most common complication during ECMO. Improving tissue perfusion, reducing blood transfusions, and preventing acute kidney failure may improve patient outcomes.
Authors: N G Smedira; N Moazami; C M Golding; P M McCarthy; C Apperson-Hansen; E H Blackstone; D M Cosgrove Journal: J Thorac Cardiovasc Surg Date: 2001-07 Impact factor: 5.209
Authors: K Kawahito; S Murata; T Yasu; H Adachi; T Ino; M Saito; Y Misawa; K Fuse; K Shimada Journal: Am J Cardiol Date: 1998-10-01 Impact factor: 2.778
Authors: Federico Pappalardo; Marina Pieri; Teresa Greco; Nicolò Patroniti; Antonio Pesenti; Antonio Arcadipane; V Marco Ranieri; Luciano Gattinoni; Giovanni Landoni; Bernhard Holzgraefe; Gernot Beutel; Alberto Zangrillo Journal: Intensive Care Med Date: 2012-11-16 Impact factor: 17.440
Authors: Sarah A Teele; Catherine K Allan; Peter C Laussen; Jane W Newburger; Kimberlee Gauvreau; Ravi R Thiagarajan Journal: J Pediatr Date: 2010-12-30 Impact factor: 4.406
Authors: Christopher H Wigfield; Joshua D Lindsey; Thomas G Steffens; Niloo M Edwards; Robert B Love Journal: J Heart Lung Transplant Date: 2007-04 Impact factor: 10.247
Authors: Satish K Rajagopal; Christopher S Almond; Peter C Laussen; Peter T Rycus; David Wypij; Ravi R Thiagarajan Journal: Crit Care Med Date: 2010-02 Impact factor: 7.598
Authors: G J Magovern; J A Magovern; D H Benckart; R R Lazzara; T Sakert; T D Maher; R E Clark Journal: Ann Thorac Surg Date: 1994-06 Impact factor: 4.330